APO RESEARCH · REPORT
Methotrexate
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Product & engineering
Understand the product.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Selected research
Industry Growth & Trends
Global Methotrexate Industry Growth and Trends Forecast to 2032
Market perspective
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
Read the full market overview
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Scope
This report provides a structured, data-driven view of the global Methotrexate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Methotrexate market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Methotrexate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Methotrexate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Methotrexate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Methotrexate Market by Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Methotrexate Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Methotrexate Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Methotrexate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate for Injection
- Methotrexate Tablets
Applications
- Used for Cancers
- Used for Rheumatoid Arthritis
- Used for Other Diseases
Companies covered
- Teva Pharmaceutical Industries
- Qualitestrx (DAVA Pharmaceuticals)
- Pfizer (Hospira)
- Roxane Laboratories
- Sine
- Maoxiang
- LingNan Pharmaceutical
- Powerdone
- Huiyu
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Methotrexate Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Methotrexate Sales Estimates and Forecasts (2021-2032)
- 1.3 Methotrexate Market by Type
- 1.3.1 Methotrexate for Injection
- 1.3.2 Methotrexate Tablets
- 1.4 Global Methotrexate Market Size by Type
- 1.4.1 Global Methotrexate Market Size Overview by Type (2021-2032)
- 1.4.2 Global Methotrexate Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Methotrexate Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Methotrexate Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Methotrexate Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Methotrexate Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Methotrexate Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Methotrexate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Methotrexate Industry Trends
- 2.2 Methotrexate Industry Drivers
- 2.3 Methotrexate Industry Opportunities and Challenges
- 2.4 Methotrexate Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Methotrexate Revenue (2021-2026)
- 3.2 Global Top Players by Methotrexate Sales (2021-2026)
- 3.3 Global Top Players by Methotrexate Price (2021-2026)
- 3.4 Global Methotrexate Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Methotrexate Major Company Production Sites & Headquarters
- 3.6 Global Methotrexate Company, Product Type & Application
- 3.7 Global Methotrexate Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Methotrexate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Methotrexate Players Market Share by Revenue in 2025
- 3.8.3 2025 Methotrexate Tier 1, Tier 2, and Tier 3
4 Methotrexate Regional Status and Outlook
- 4.1 Global Methotrexate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Methotrexate Historic Market Size by Region
- 4.2.1 Global Methotrexate Sales in Volume by Region (2021-2026)
- 4.2.2 Global Methotrexate Sales in Value by Region (2021-2026)
- 4.2.3 Global Methotrexate Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Methotrexate Forecasted Market Size by Region
- 4.3.1 Global Methotrexate Sales in Volume by Region (2027-2032)
- 4.3.2 Global Methotrexate Sales in Value by Region (2027-2032)
- 4.3.3 Global Methotrexate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Methotrexate by Application
- 5.1 Methotrexate Market by Application
- 5.1.1 Used for Cancers
- 5.1.2 Used for Rheumatoid Arthritis
- 5.1.3 Used for Other Diseases
- 5.2 Global Methotrexate Market Size by Application
- 5.2.1 Global Methotrexate Market Size Overview by Application (2021-2032)
- 5.2.2 Global Methotrexate Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Methotrexate Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Methotrexate Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Methotrexate Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Methotrexate Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Methotrexate Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Methotrexate Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceutical Industries
- 6.1.1 Teva Pharmaceutical Industries Company Information
- 6.1.2 Teva Pharmaceutical Industries Business Overview
- 6.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
- 6.1.5 Teva Pharmaceutical Industries Recent Developments
- 6.2 Qualitestrx (DAVA Pharmaceuticals)
- 6.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
- 6.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
- 6.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
- 6.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
- 6.3 Pfizer (Hospira)
- 6.3.1 Pfizer (Hospira) Company Information
- 6.3.2 Pfizer (Hospira) Business Overview
- 6.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
- 6.3.5 Pfizer (Hospira) Recent Developments
- 6.4 Roxane Laboratories
- 6.4.1 Roxane Laboratories Company Information
- 6.4.2 Roxane Laboratories Business Overview
- 6.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Roxane Laboratories Methotrexate Product Portfolio
- 6.4.5 Roxane Laboratories Recent Developments
- 6.5 Sine
- 6.5.1 Sine Company Information
- 6.5.2 Sine Business Overview
- 6.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sine Methotrexate Product Portfolio
- 6.5.5 Sine Recent Developments
- 6.6 Maoxiang
- 6.6.1 Maoxiang Company Information
- 6.6.2 Maoxiang Business Overview
- 6.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Maoxiang Methotrexate Product Portfolio
- 6.6.5 Maoxiang Recent Developments
- 6.7 LingNan Pharmaceutical
- 6.7.1 LingNan Pharmaceutical Company Information
- 6.7.2 LingNan Pharmaceutical Business Overview
- 6.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
- 6.7.5 LingNan Pharmaceutical Recent Developments
- 6.8 Powerdone
- 6.8.1 Powerdone Company Information
- 6.8.2 Powerdone Business Overview
- 6.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Powerdone Methotrexate Product Portfolio
- 6.8.5 Powerdone Recent Developments
- 6.9 Huiyu
- 6.9.1 Huiyu Company Information
- 6.9.2 Huiyu Business Overview
- 6.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Huiyu Methotrexate Product Portfolio
- 6.9.5 Huiyu Recent Developments
7 North America by Country
- 7.1 North America Methotrexate Sales by Country
- 7.1.1 North America Methotrexate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Methotrexate Sales by Country (2021-2026)
- 7.1.3 North America Methotrexate Sales Forecast by Country (2027-2032)
- 7.2 North America Methotrexate Market Size by Country
- 7.2.1 North America Methotrexate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Methotrexate Market Size by Country (2021-2026)
- 7.2.3 North America Methotrexate Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Methotrexate Sales by Country
- 8.1.1 Europe Methotrexate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Methotrexate Sales by Country (2021-2026)
- 8.1.3 Europe Methotrexate Sales Forecast by Country (2027-2032)
- 8.2 Europe Methotrexate Market Size by Country
- 8.2.1 Europe Methotrexate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Methotrexate Market Size by Country (2021-2026)
- 8.2.3 Europe Methotrexate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Methotrexate Sales by Country
- 9.1.1 Asia-Pacific Methotrexate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Methotrexate Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Methotrexate Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Methotrexate Market Size by Country
- 9.2.1 Asia-Pacific Methotrexate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Methotrexate Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Methotrexate Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Methotrexate Sales by Country
- 10.1.1 South America Methotrexate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Methotrexate Sales by Country (2021-2026)
- 10.1.3 South America Methotrexate Sales Forecast by Country (2027-2032)
- 10.2 South America Methotrexate Market Size by Country
- 10.2.1 South America Methotrexate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Methotrexate Market Size by Country (2021-2026)
- 10.2.3 South America Methotrexate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Methotrexate Sales by Country
- 11.1.1 Middle East and Africa Methotrexate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Methotrexate Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Methotrexate Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Methotrexate Market Size by Country
- 11.2.1 Middle East and Africa Methotrexate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Methotrexate Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Methotrexate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Methotrexate Value Chain Analysis
- 12.1.1 Methotrexate Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Methotrexate Production Mode & Process
- 12.2 Methotrexate Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Methotrexate Distributors
- 12.2.3 Methotrexate Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst